This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2004 Nov 25;351(22):2330-2.

doi: 10.1056/NEJMe048314. Epub 2004 Nov 3.

Intradermal influenza vaccination--can less be more?

John R La Montagne, Anthony S Fauci

PMID: 15525715
DOI: 10.1056/NEJMe048314

Free article

Editorial

Intradermal influenza vaccination--can less be more?

John R La Montagne et al. N Engl J Med. 2004.

Free article

. 2004 Nov 25;351(22):2330-2.

doi: 10.1056/NEJMe048314. Epub 2004 Nov 3.

Authors

John R La Montagne, Anthony S Fauci

PMID: 15525715
DOI: 10.1056/NEJMe048314

No abstract available

PubMed Disclaimer

Comment in

Intradermal vaccination against influenza.
Manian FA. Manian FA. N Engl J Med. 2005 Mar 10;352(10):1044-6; author reply 1044-6. N Engl J Med. 2005. PMID: 15761999 No abstract available.
Intradermal vaccination against influenza.
Kilbourne ED. Kilbourne ED. N Engl J Med. 2005 Mar 10;352(10):1044-6; author reply 1044-6. N Engl J Med. 2005. PMID: 15762000 No abstract available.

Comment on

Serum antibody responses after intradermal vaccination against influenza.
Belshe RB, Newman FK, Cannon J, Duane C, Treanor J, Van Hoecke C, Howe BJ, Dubin G. Belshe RB, et al. N Engl J Med. 2004 Nov 25;351(22):2286-94. doi: 10.1056/NEJMoa043555. Epub 2004 Nov 3. N Engl J Med. 2004. PMID: 15525713 Clinical Trial.
Dose sparing with intradermal injection of influenza vaccine.
Kenney RT, Frech SA, Muenz LR, Villar CP, Glenn GM. Kenney RT, et al. N Engl J Med. 2004 Nov 25;351(22):2295-301. doi: 10.1056/NEJMoa043540. Epub 2004 Nov 3. N Engl J Med. 2004. PMID: 15525714 Clinical Trial.

Similar articles

[Prevention of influenza by use of intradermal vaccination].
Kyncl J. Kyncl J. Cas Lek Cesk. 2009;148(5):191-3. Cas Lek Cesk. 2009. PMID: 19642311 Czech.
Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.
Holland D, Booy R, De Looze F, Eizenberg P, McDonald J, Karrasch J, McKeirnan M, Salem H, Mills G, Reid J, Weber F, Saville M. Holland D, et al. J Infect Dis. 2008 Sep 1;198(5):650-8. doi: 10.1086/590434. J Infect Dis. 2008. PMID: 18652550 Clinical Trial.
Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study.
Arnou R, Icardi G, De Decker M, Ambrozaitis A, Kazek MP, Weber F, Van Damme P. Arnou R, et al. Vaccine. 2009 Dec 9;27(52):7304-12. doi: 10.1016/j.vaccine.2009.10.033. Epub 2009 Oct 20. Vaccine. 2009. PMID: 19849996 Clinical Trial.
Immunogenicity and protective efficacy of influenza vaccination.
Hannoun C, Megas F, Piercy J. Hannoun C, et al. Virus Res. 2004 Jul;103(1-2):133-8. doi: 10.1016/j.virusres.2004.02.025. Virus Res. 2004. PMID: 15163501 Review. No abstract available.
The use of inactivated influenza vaccine in children.
Wright PF. Wright PF. Semin Pediatr Infect Dis. 2006 Oct;17(4):200-5. doi: 10.1053/j.spid.2006.08.004. Semin Pediatr Infect Dis. 2006. PMID: 17055371 Review.

See all similar articles

Cited by

Phase 1, randomized, rater and participant blinded placebo-controlled study of the safety, reactogenicity, tolerability and immunogenicity of H1N1 influenza vaccine delivered by VX-103 (a MIMIX microneedle patch [MAP] system) in healthy adults.
Garg N, Tellier G, Vale N, Kluge J, Portman JL, Markowska A, Tussey L. Garg N, et al. PLoS One. 2024 Jun 6;19(6):e0303450. doi: 10.1371/journal.pone.0303450. eCollection 2024. PLoS One. 2024. PMID: 38843267 Free PMC article. Clinical Trial.
Quadrivalent Vaccines for the Immunization of Adults against Influenza: A Systematic Review of Randomized Controlled Trials.
Mannocci A, Pellacchia A, Millevolte R, Chiavarini M, de Waure C. Mannocci A, et al. Int J Environ Res Public Health. 2022 Aug 1;19(15):9425. doi: 10.3390/ijerph19159425. Int J Environ Res Public Health. 2022. PMID: 35954781 Free PMC article. Review.
Review of Influenza Virus Vaccines: The Qualitative Nature of Immune Responses to Infection and Vaccination Is a Critical Consideration.
Chan L, Alizadeh K, Alizadeh K, Fazel F, Kakish JE, Karimi N, Knapp JP, Mehrani Y, Minott JA, Morovati S, Rghei A, Stegelmeier AA, Vanderkamp S, Karimi K, Bridle BW. Chan L, et al. Vaccines (Basel). 2021 Sep 1;9(9):979. doi: 10.3390/vaccines9090979. Vaccines (Basel). 2021. PMID: 34579216 Free PMC article. Review.
Strategies for Vaccine Prioritization and Mass Dispensing.
Lee EK, Li ZL, Liu YK, LeDuc J. Lee EK, et al. Vaccines (Basel). 2021 May 14;9(5):506. doi: 10.3390/vaccines9050506. Vaccines (Basel). 2021. PMID: 34068985 Free PMC article.
Immunogenicity and Safety of Reduced-Dose Intradermal vs Intramuscular Influenza Vaccines: A Systematic Review and Meta-analysis.
Egunsola O, Clement F, Taplin J, Mastikhina L, Li JW, Lorenzetti DL, Dowsett LE, Noseworthy T. Egunsola O, et al. JAMA Netw Open. 2021 Feb 1;4(2):e2035693. doi: 10.1001/jamanetworkopen.2020.35693. JAMA Netw Open. 2021. PMID: 33560425 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information